![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HS3ST3A1 |
Gene summary for HS3ST3A1 |
![]() |
Gene information | Species | Human | Gene symbol | HS3ST3A1 | Gene ID | 9955 |
Gene name | heparan sulfate-glucosamine 3-sulfotransferase 3A1 | |
Gene Alias | 3-OST-3A | |
Cytomap | 17p12 | |
Gene Type | protein-coding | GO ID | GO:0006022 | UniProtAcc | Q9Y663 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9955 | HS3ST3A1 | CCI_1 | Human | Cervix | CC | 9.52e-06 | 3.49e-01 | 0.528 |
9955 | HS3ST3A1 | CCI_2 | Human | Cervix | CC | 2.02e-20 | 1.24e+00 | 0.5249 |
9955 | HS3ST3A1 | P9T-E | Human | Esophagus | ESCC | 7.64e-18 | 5.12e-01 | 0.1131 |
9955 | HS3ST3A1 | P21T-E | Human | Esophagus | ESCC | 2.37e-12 | 2.05e-01 | 0.1617 |
9955 | HS3ST3A1 | P24T-E | Human | Esophagus | ESCC | 1.67e-15 | 6.93e-01 | 0.1287 |
9955 | HS3ST3A1 | P32T-E | Human | Esophagus | ESCC | 5.19e-03 | 8.62e-02 | 0.1666 |
9955 | HS3ST3A1 | P36T-E | Human | Esophagus | ESCC | 1.64e-09 | 4.47e-01 | 0.1187 |
9955 | HS3ST3A1 | P37T-E | Human | Esophagus | ESCC | 6.46e-10 | 2.52e-01 | 0.1371 |
9955 | HS3ST3A1 | P39T-E | Human | Esophagus | ESCC | 4.12e-05 | 2.21e-01 | 0.0894 |
9955 | HS3ST3A1 | P62T-E | Human | Esophagus | ESCC | 3.90e-12 | 3.96e-01 | 0.1302 |
9955 | HS3ST3A1 | P76T-E | Human | Esophagus | ESCC | 4.66e-03 | 1.17e-01 | 0.1207 |
9955 | HS3ST3A1 | P107T-E | Human | Esophagus | ESCC | 2.26e-07 | 3.02e-01 | 0.171 |
9955 | HS3ST3A1 | P128T-E | Human | Esophagus | ESCC | 4.39e-02 | 3.13e-01 | 0.1241 |
9955 | HS3ST3A1 | P130T-E | Human | Esophagus | ESCC | 5.48e-25 | 6.19e-01 | 0.1676 |
9955 | HS3ST3A1 | ATC09 | Human | Thyroid | ATC | 3.46e-09 | 4.03e-01 | 0.2871 |
9955 | HS3ST3A1 | ATC11 | Human | Thyroid | ATC | 1.60e-07 | 4.72e-01 | 0.3386 |
9955 | HS3ST3A1 | ATC12 | Human | Thyroid | ATC | 3.28e-16 | 3.47e-01 | 0.34 |
9955 | HS3ST3A1 | ATC1 | Human | Thyroid | ATC | 1.26e-09 | 4.51e-01 | 0.2878 |
9955 | HS3ST3A1 | ATC2 | Human | Thyroid | ATC | 8.57e-18 | 1.13e+00 | 0.34 |
9955 | HS3ST3A1 | ATC3 | Human | Thyroid | ATC | 1.38e-16 | 6.49e-01 | 0.338 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006024 | Esophagus | ESCC | glycosaminoglycan biosynthetic process | 45/8552 | 75/18723 | 8.75e-03 | 3.08e-02 | 45 |
GO:0006023 | Esophagus | ESCC | aminoglycan biosynthetic process | 47/8552 | 79/18723 | 9.29e-03 | 3.23e-02 | 47 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HS3ST3A1 | SNV | Missense_Mutation | c.625N>A | p.Gly209Arg | p.G209R | Q9Y663 | protein_coding | deleterious(0.03) | possibly_damaging(0.585) | TCGA-A5-A2K3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD | |
HS3ST3A1 | SNV | Missense_Mutation | novel | c.569G>A | p.Arg190His | p.R190H | Q9Y663 | protein_coding | deleterious(0.03) | benign(0.282) | TCGA-AJ-A3OJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
HS3ST3A1 | SNV | Missense_Mutation | novel | c.1094G>A | p.Gly365Asp | p.G365D | Q9Y663 | protein_coding | deleterious(0.02) | probably_damaging(0.998) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
HS3ST3A1 | SNV | Missense_Mutation | novel | c.692N>T | p.Ala231Val | p.A231V | Q9Y663 | protein_coding | deleterious(0.03) | benign(0.106) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HS3ST3A1 | SNV | Missense_Mutation | novel | c.1158N>A | p.Phe386Leu | p.F386L | Q9Y663 | protein_coding | deleterious(0) | probably_damaging(0.981) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD |
HS3ST3A1 | SNV | Missense_Mutation | c.809N>T | p.Thr270Met | p.T270M | Q9Y663 | protein_coding | deleterious(0.01) | possibly_damaging(0.683) | TCGA-BG-A18B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
HS3ST3A1 | SNV | Missense_Mutation | c.647C>T | p.Thr216Met | p.T216M | Q9Y663 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-D1-A15X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
HS3ST3A1 | SNV | Missense_Mutation | c.974G>A | p.Arg325His | p.R325H | Q9Y663 | protein_coding | deleterious(0.03) | probably_damaging(0.964) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
HS3ST3A1 | SNV | Missense_Mutation | novel | c.1174N>A | p.Leu392Ile | p.L392I | Q9Y663 | protein_coding | tolerated(0.37) | benign(0.007) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
HS3ST3A1 | SNV | Missense_Mutation | novel | c.914N>A | p.Arg305His | p.R305H | Q9Y663 | protein_coding | deleterious(0.02) | benign(0.019) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |